Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.28 BRL | -5.55% | -5.67% | -2.65% |
Apr. 16 | Lummus and Braskem to Partner on Electrified Cracking Heater for Decarbonization | CI |
Mar. 20 | Braskem Q4 Net Loss Shrinks, Revenue Drops -- Shares Surge | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.76 for the current period. Therefore, the company is undervalued.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.65% | 3.43B | C+ | ||
+4.41% | 103B | A- | ||
+1.20% | 68.41B | A- | ||
+44.29% | 39.97B | B | ||
+15.99% | 38.97B | B | ||
+5.14% | 33.12B | A- | ||
+5.29% | 19.41B | B- | ||
+12.32% | 16.73B | C+ | ||
+8.31% | 15.34B | B | ||
+17.69% | 15.07B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BRKM5 Stock
- Ratings Braskem S.A.